A vs HCA: fair value comparison
Agilent Technologies, Inc. and HCA Healthcare, Inc. · Updated 2026-09-12
A currently screens as undervalued while HCA screens as fairly valued. Within Healthcare, A currently sits closer to the top of our discount ranking. A carries the stronger quality grade.
| A | HCA | |
|---|---|---|
| Verdict | Undervalued | Fairly valued |
| Last price | $146.93 | $426.94 |
| 12-month range | $114.52–$150.10 | $370.96–$532.92 |
| Sector rank | #57 of 113 Healthcare | #62 of 113 Healthcare |
| Quality grade | B | D |
| Leverage | Moderate | Low |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: A fair value analysis · HCA fair value analysis